Concord Drugs Stock Price - ₹69.10 | Healthcare | askfuzz

Sign in to fuzzto save your conversations, follow your research and come back anytime.

‌

‌
‌

‌
‌
‌

‌
‌
‌
‌
‌
‌

Concord Drugs Stock Price - ₹69.10 | Healthcare | askfuzz

Quarterly Results

₹Cr

Metric (₹ crore)	Q4 FY22	Q1 FY23	Q2 FY23	Q3 FY23	Q4 FY23	Q1 FY24	Q2 FY24	Q3 FY24	Q4 FY24	Q1 FY25	Q2 FY25	Q3 FY25	Q4 FY25	Q1 FY26	Q2 FY26	Q3 FY26	Q4 FY26	Q1 FY27
Sales	15.48	12.54	13.72	13.53	12.31	8.98	7.53	12.78	15.64	11.69	12.37	10.8	10.39	13.61	10.28	16.99	37.9	20.95
Expenses	14.81	11.56	12.53	12.08	11.34	7.52	5.91	12.15	15.29	10.86	11.49	9.41	9.35	12.59	9.18	16.05	36.4	18.66
EBITDA	0.67	0.98	1.19	1.45	0.97	1.46	1.62	0.63	0.35	0.83	0.88	1.39	1.04	1.02	1.1	0.94	1.5	2.29
Depreciation	0.37	0.39	0.53	0.38	0.33	0.38	0.39	0.39	0.39	0.34	0.34	0.37	0.38	0.37	0.34	0.31	0.35	0.35
EBIT	0.3	0.59	0.66	1.07	0.64	1.08	1.23	0.24	-0.04	0.49	0.54	1.02	0.66	0.65	0.76	0.63	1.15	1.94
Interest	0.23	0.34	0.42	0.45	0.5	0.44	0.43	0.5	0.5	0.45	0.47	0.5	0.61	0.49	0.49	0.34	0.4	0.4
Profit Before Tax	0.07	0.25	0.24	0.62	0.14	0.64	0.8	-0.26	-0.54	0.04	0.07	0.52	0.05	0.16	0.27	0.29	0.75	1.54
Net Profit	0.03	0.19	0.18	0.45	0.16	0.49	0.56	-0.24	-0.34	0.03	0.04	0.23	0.04	0.12	0.19	0.22	0.53	1.11
EPS	0.03	0.21	0.21	0.52	0.17	0.53	0.6	-0.24	-0.34	0.03	0.04	0.23	0.04	0.12	0.19	0.16	0.47	0.85

Cashflow

₹Cr

Metric (₹ crore)	FY22	FY23	FY24	FY25	FY26
Operating Cash Flow	0.77	1.66	0.79	3.72	-5.75
Investing Cash Flow	-2.44	-2.27	-1.01	-2.32	-1.13
Financing Cash Flow	1.68	0.62	0.28	-1.43	7.04
Net Cash Flow	0.01	0.01	0.06	-0.03	0.16

Balance Sheet

Annual

₹Cr

Metric (₹ crore)	FY22	FY23	FY24	FY25	FY26
Equity / Shareholders' Funds	28.36	31.7	33.82	34.11	48.51
Total Liabilities	28.08	26.53	24.99	31.03	26.37
Total Assets	56.45	58.23	58.81	65.14	74.89

Shareholding

₹94 CrMarket Cap

Promoter & promoter group (45.08%)

Public & others (54.92%)